File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) In Children

TitleGemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) In Children
Authors
Issue Date2017
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.jpho-online.com
Citation
Journal of Pediatric Hematology/Oncology, 2017 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/249298
ISSN
2017 Impact Factor: 1.06
2015 SCImago Journal Rankings: 0.452
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLiu, APY-
dc.contributor.authorLeung, AWK-
dc.contributor.authorCheuk, DKL-
dc.contributor.authorLee, V-
dc.contributor.authorHa, SY-
dc.date.accessioned2017-11-21T03:00:13Z-
dc.date.available2017-11-21T03:00:13Z-
dc.date.issued2017-
dc.identifier.citationJournal of Pediatric Hematology/Oncology, 2017-
dc.identifier.issn1077-4114-
dc.identifier.urihttp://hdl.handle.net/10722/249298-
dc.languageeng-
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.jpho-online.com-
dc.relation.ispartofJournal of Pediatric Hematology/Oncology-
dc.rightsThis is a non-final version of an article published in final form in (provide complete journal citation)-
dc.titleGemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) In Children-
dc.typeArticle-
dc.identifier.emailLiu, APY: apyliu@hku.hk-
dc.identifier.authorityLiu, APY=rp01357-
dc.identifier.doi10.1097/MPH.0000000000001010-
dc.identifier.hkuros283227-
dc.identifier.isiWOS:000428181500034-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats